Drug Trial News

RSS
FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Butler Hospital launches international Alzheimer's disease prevention study

Butler Hospital launches international Alzheimer's disease prevention study

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age

New first line combination therapy shows promising results in patients with advanced NSCLC

New first line combination therapy shows promising results in patients with advanced NSCLC

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

New drugs Erenumab and Fremanezumab show promise for migraine

New drugs Erenumab and Fremanezumab show promise for migraine

New immunotherapy study shows positive results in chronic migraine sufferers

New immunotherapy study shows positive results in chronic migraine sufferers

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

New cancer drug begins clinical trial in human patients with rare brain tumor

New cancer drug begins clinical trial in human patients with rare brain tumor

New study tests pain treatment in humans

New study tests pain treatment in humans

Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients